Two Sigma Investments, LP Novo Cure LTD Put Options Transaction History

Two Sigma Investments, LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $435,464 - $707,542	-5,800 Reduced 50.0%	5,800 $435,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $871,275 - $1.46 Million	7,500 Added 182.93%	11,600 $1.35 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $1.32 Million - $2.28 Million	-10,100 Reduced 71.13%	4,100 $909,000
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $1.26 Million - $1.95 Million	11,200 Added 373.33%	14,200 $2.46 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $893,970 - $1.71 Million	-15,400 Reduced 83.7%	3,000 $334,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $91,520 - $119,056	-1,600 Reduced 8.0%	18,400 $1.09 Million
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $513,450 - $861,750	9,000 Added 81.82%	20,000 $1.35 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $1.37 Million - $1.89 Million	-20,100 Reduced 64.63%	11,000 $927,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $1.55 Million - $2.45 Million	25,100 Added 418.33%	31,100 $2.33 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $253,320 - $379,380	6,000 New	6,000 $379,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.16B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.